Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
PubMed
29579186
DOI
10.1093/europace/eux380
PII: 4944677
Knihovny.cz E-zdroje
- MeSH
- defibrilátory implantabilní MeSH
- elektrofyziologické techniky kardiologické metody MeSH
- kardiochirurgické výkony * škodlivé účinky metody MeSH
- kardiologie * metody trendy MeSH
- katetrizační ablace metody MeSH
- lidé MeSH
- management péče o pacienta * metody normy MeSH
- mladý dospělý MeSH
- náhlá srdeční smrt * etiologie prevence a kontrola MeSH
- srdeční arytmie * diagnóza etiologie terapie MeSH
- srdeční resynchronizační terapie metody MeSH
- vrozené srdeční vady * komplikace chirurgie MeSH
- Check Tag
- lidé MeSH
- mladý dospělý MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Evropa MeSH
The population of patients with congenital heart disease (CHD) is continuously increasing with more and more patients reaching adulthood. A significant portion of these young adults will suffer from arrhythmias due to the underlying congenital heart defect itself or as a sequela of interventional or surgical treatment. The medical community will encounter an increasing challenge as even most of the individuals with complex congenital heart defects nowadays become young adults. Within the past 20 years, management of patients with arrhythmias has gained remarkable progress including pharmacological treatment, catheter ablation, and device therapy. Catheter ablation in patients with CHD has paralleled the advances of this technology in pediatric and adult patients with structurally normal hearts. Growing experience and introduction of new techniques like the 3D mapping systems into clinical practice have been particularly beneficial for this growing population of patients with abnormal cardiac anatomy and physiology. Finally, device therapies allowing maintanence of chronotropic competence and AV conduction, improving haemodynamics by cardiac resynchronization, and preventing sudden death are increasingly used. For pharmacological therapy, ablation procedures, and device therapy decision making requires a deep understanding of the individual pathological anatomy and physiology as well as detailed knowledge on natural history and long-term prognosis of our patients. Composing expert opinions from cardiology and paediatric cardiology as well as from non-invasive and invasive electrophysiology this position paper was designed to state the art in management of young individuals with congenital heart defects and arrhythmias.
Academical Medical Center Amsterdam The Netherlands
Center for Electrophysiology at Heart Center Bremen Bremen Germany
Congenital Cardiac Surgery Unit Policlinico San Donato University and Research Hospital Milan Italy
Department of Cardiology Arrhythmia Unit Hospital la Paz Madrid Spain
Department of Cardiology Leiden University Medical Center Leiden The Netherlands
Department of Cardiology Maastricht University Medical Center Maastricht Netherlands
Department of Electrophysiology University Leipzig Heart Center Leipzig Germany
Department of Heart Disease Haukeland University Hospital Bergen Norway
Department of Pediatric Cardiology Leiden University Medical Center Leiden The Netherlands
HRS Representative Pediatric Electrophysiology Cleveland Clinic Children's Cleveland OH USA
PACES Representative Department of Cardiology Boston Childrens Hospital Boston MA USA
Royal Brompton and Harefield Hospital London UK
University Hospital Muenster Muenster Germany
Westpfalz Klinikum Kaiserslautern Children's Hospital Kaiserslautern Germany
Citace poskytuje Crossref.org
